We are developing a new class of targeted psychedelic agents to selectively intervene with serotonin receptors. Using synthetic biology, genome engineering tools we create well-known and new psychedelic derivatives used in preclinical and clinical research to eradicate most debilitating mental health disorders.
| Website | https://www.psylink.io |
| Employees | 4 (1 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Psychedelic Therapeutics, Targeted Drug Delivery, Synthetic Biology, Genome Engineering, Preclinical Research, Clinical Trials, Drug Development, Biotechnology, Pharmaceutical Research, Psychedelic Medicine, Neurological Disorders, Innovative Therapies, Receptor Pharmacology, Precision Medicine, New Drug Discovery, Therapeutic Agents, Biopharmaceutical |
Looking for a particular Psylink employee's phone or email?
Laura Korsakova is the Co-founder and CEO of Psylink.
1 people are employed at Psylink.